Atossa Therapeutics (NASDAQ: ATOS) deepens Z-endoxifen bet as 2025 losses widen and rare disease optionality grows
Read More 2 minute read Pharma Industry News Zydus Lifesciences bags FDA approval for Lacosamide Tablets in seizures Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has recently received final approval from the United… byPallavi MadhirajuDecember 16, 2023